FOMAT Medical is a specialist in Phase 2, 3 & Phase 4 clinical trials in South America. FOMAT is a Site Management Organization providing services that specialize in the development and management of clinical trials. We meet expectations by concentrating on…
New Approaches to Virtual Screening
Ivan Solt, Anna Tomin, Krisztian Niesz, ChemAxon Ltd. Virtual screening (VS) aims to reduce the enormous virtual space of chemical compounds (a practical virtual library might comprise ~1015 molecules) to a more manageable number for further synthesis and screening against biological…
Un estudio del NIH resuelve el misterio de las células ováricas y arroja nueva luz sobre los trastornos reproductivos.
Scientists at the National Institutes of Health have solved a long-standing mystery about the origin of one of the cell types that make up the ovary. The team also discovered how ovarian cells share information during development of an ovarian follicle,…
New Clarity’ Against Alzheimer’s
GAZETTE: Where are we with Alzheimer’s, medically and scientifically? TANZI: We’re a lot farther along now than we were even last year. Back in 1986, as a Harvard student in the graduate school, my doctoral study was to discover the first Alzheimer’s gene,…
Research Finds “Fuzzy Thinking” Effect in Depression, Biopolar Disorder is Real
People with depression or bipolar disorder often feel their thinking ability has gotten “fuzzy”, or less sharp than before their symptoms began. Now, researchers have shown in a very large study that effect is indeed real – and rooted in brain…
Los cambios en los telómeros predicen el cáncer
A distinct pattern in the changing length of blood telomeres, the protective end caps on our DNA strands, can predict cancer many years before actual diagnosis, according to a new study from Northwestern Medicine in collaboration with Harvard University. The pattern…
Potentially Reversible Driver of Aging Found
Using stem cells and gene editing, Salk Institute researchers have unearthed a major driver of aging research, from cancer to diabetes. That driver: loss of heterochromatin, which is potentially reversible as it is an epigenetic process that does not initially forge…
Prostate Cancer Combination Treatment Could Beat Disease at Its Own Game: Early Study
When prostate cancer advances to the point of spreading, the larger and more stubborn tumors develop cells that suppress the body’s immune response – and defeat doctors’ attempts to launch an attack on it, experts said. But through chemoimmunotherapy, a chemical…
Researchers Discover How Aspirin Fights Cancer
Get today’s drug discovery & development headlines and news – Sign up now! Taking aspirin reduces a person’s risk of colorectal cancer, but the molecular mechanisms involved have remained unknown until a recent discovery by The Hormel Institute, affiliated with the…
3 Ways Technology is Changing the Face of Drug Discovery & Development
While personalized medicine has been a goal for some time, there have been several obstacles. Although there has been an explosion in genomic data, the corresponding clinical utility for this data has been slow to be validated. Data from tissue images,…